Combining these two atomic and molecular testing methods will be pursued next in a systematic way for both commercial products and model compounds.
Although several PCR based molecular testing methods are being emerged, there is no universal assay available for genotyping of cancer biomarkers.
High-throughput, yet simple, reliable, and cost-effective molecular testing methods are crucial for efficiently utilizing vast quantities of genetic information to elucidate mechanisms of disease, identify potential targets for therapy and diagnosis, track the identity or origin of subject organisms, and personalize treatment protocols for individual patients.
Serological testing for influenza infection alone, rather than molecular testing methods, may have underestimated the true number of influenza infections [ 24].
Molecular testing methods might help in identifying patients at high risk for therapy-related complications and guide risk-adapted screening and intervention strategies.
However, various molecular assays exist which are not yet fully standardised, and the diagnostic performance of commercially available kits may differ considerably from in-house molecular testing methods in use at different laboratories.
Nasopharyngeal swab (NP) samples, bronchoalveolar lavage (BAL), and cerebrospinal fluid (CSF) samples tested positive for influenza A(H5N1) virus by various molecular testing methods, including sequencing, at the Provincial Laboratory for Public Health and the National Microbiology Laboratory, Public Health Agency of Canada (1 ).
Although novel molecular testing methods appear promising in overcoming some of the present diagnostic limitations of conventional blood sampling in children, they still need to solidly prove their accuracy and reliability in clinical practice.
Guidelines recommend laboratories use validated molecular testing methods with sufficient performance characteristics 16; options include direct sequencing 17, immunohistochemistry (IHC) 17, and polymerase chain reaction-based analysis (e.g., Scorpion Amplification Refractory Mutation System technology [DxS]) 18.
Other than the potential long-term microbiota adjustment to a new diet [ 42] the accumulated effect of meloxicam should also be considered, and in the absence of clinical or histologic abnormalities, only advanced molecular testing methods had the sensitivity to detect subtle changes in the rabbit's GIT microbiota.
